LEXICON PHARMACEUTICALS INC. - COMMON STOCK

Lexicon Announces Series of Presentations Relating to LX9211, Its Investigational Drug for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)

07 سبتمبر 2023 09:00:00 بحسب Nasdaq GlobeNewswire

Lexicon to Present Analyses of INPEFA™ (sotagliflozin) Clinical Study Results and Changing Patterns of Heart Failure Diagnoses at the European Society of Cardiology (ESC) Congress 2023

21 أغسطس 2023 09:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

17 أغسطس 2023 09:45:24 بحسب NetDania Notify

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

16 أغسطس 2023 09:45:10 بحسب NetDania Notify

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

15 أغسطس 2023 10:01:50 بحسب NetDania Notify

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

14 أغسطس 2023 09:45:43 بحسب NetDania Notify

Published Analysis of Sotagliflozin (INPEFA(TM)) Clinical Data Demonstrates Significant Reductions in the Risk of Hospital Readmissions for Heart Failure

08 أغسطس 2023 09:00:01 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

07 أغسطس 2023 13:43:27 بحسب NetDania Notify

Lexicon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

03 أغسطس 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 3, 2023

28 يوليو 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Lexicon Elects Diane E. Sullivan to Board of Directors

28 يوليو 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Lexicon Announces Planned Advancement of LX9211 Into Late-Stage Development

23 يونيو 2023 20:45:00 بحسب Nasdaq GlobeNewswire

Lexicon to Present Study Results Relating to LX9211 and INPEFA™ (Sotagliflozin) at the American Diabetes Association’s 83rd Scientific Sessions

20 يونيو 2023 08:00:02 بحسب Nasdaq GlobeNewswire

UPDATE: Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure

15 يونيو 2023 17:00:30 بحسب Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Participate in the Jefferies 2023 Global Healthcare Conference

06 يونيو 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Lexicon Announces Closing of Public Offering and Concurrent Private Placement, Including Full Exercise of Options to Purchase Additional Shares

05 يونيو 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement

01 يونيو 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Lexicon Announces Proposed Public Offering of Common Stock

31 مايو 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure

26 مايو 2023 16:05:00 بحسب Nasdaq GlobeNewswire

New Analysis Finds Sotagliflozin to Be a Cost-Effective Treatment at Commonly Accepted Willingness-to-Pay Threshold in Patients with Worsening Heart Failure

10 مايو 2023 16:30:00 بحسب Nasdaq GlobeNewswire